Preannouncment: Crowdinvesting campaign on aescuvest
In the fight against coronaviruses the team of the ImmunoLogik identified a promising lead candidate for the treatment of people infected with SARS-CoV-2.
For the funding of the next steps in the drug development of the lead candidate IML-206 the ImmunoLogik starts a new crowdinvesting campaign on aescuvest.de and moneywell.de in the context of the #CrowdBeatsCorona alliance.
You find more information about the preannouncement in aescuvest’s blog.
In order not to miss the start of the crowdinvesting campaign, subscribe to aescuvest’s newsletter.